FTC commissioners zero in on whether LabMD harmed consumers

Well before the contentious battle between the Federal Trade Commission and LabMD reached the courtroom for oral arguments before the agency’s commissioners, Michael J. Daugherty, the medical company’s pugnacious CEO, was itching to move the fight into federal court. Daugherty has been adamant for years — dating from before the